Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy.
Saved in:
| Title: | Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy. |
|---|---|
| Authors: | Doreswamy CM; School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.; Anthem Biosciences Limited, Bommasandra Industrial Area, Bengaluru, Karnataka, 56099, India., Seekallu S; Anthem Biosciences Limited, Bommasandra Industrial Area, Bengaluru, Karnataka, 56099, India., Venkataramaiah SB; Anthem Biosciences Limited, Bommasandra Industrial Area, Bengaluru, Karnataka, 56099, India., Umesh MC; Anthem Biosciences Limited, Bommasandra Industrial Area, Bengaluru, Karnataka, 56099, India., Devi CS; School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. csubathradevi@vit.ac.in. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 May 24; Vol. 151 (5), pp. 174. Date of Electronic Publication: 2025 May 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
